Day: March 24, 2026

us corporate news

Aureus Greenway Holdings Provides $20 Million Bridge Loan to Powerus Ahead of Planned Merger

Minichart

March 24, 2026

Aureus Greenway Holdings Inc. Provides \$20 Million Bridge L...

Continue Reading 0

us corporate news

The InterGroup Corporation Files Form 8-K with SEC – Company Details, Address, and Stock Information (March 19, 2026)

Minichart

March 24, 2026

The InterGroup Corporation Files Form 8-K: Change in Auditor...

Continue Reading 0

us corporate news

Ultralife Corporation 2025 Annual Report: Strategic Rebranding, Battery Innovations, and Market Expansion

Minichart

March 24, 2026

Ultralife Corporation 2025 10-K Report: Detailed Investor Su...

Continue Reading 0

us corporate news

TGE Value Creative Solutions Corp 2025 Annual Report: SPAC Business Overview, Strategy, and Risk Factors in Media, Entertainment & Lifestyle Sectors

Minichart

March 24, 2026

TGE Value Creative Solutions Corp 2025 Annual Report: Key In...

Continue Reading 0

us corporate news

Talphera, Inc. (Formerly AcelRx) 2025 Annual Report: Business Overview, Key Risks, and Regulatory Challenges in Specialty Pharmaceuticals

Minichart

March 24, 2026

Talphera, Inc. 2025 Annual Report: Investor Analysis & Highl...

Continue Reading 0

us corporate news

Semtech Corporation 2026 Annual Report: Financials, Risk Factors, and Corporate Governance Overview

Minichart

March 24, 2026

Semtech Corporation 2026 Annual Report: Key Insights for Inv...

Continue Reading 0

us corporate news

Yunhong Green CTI Ltd. 2025 Annual Report: Business Overview, Strategies, Product Lines, and Financial Results

Minichart

March 24, 2026

Yunhong Green CTI Ltd. 2025 Annual Report: Key Investor High...

Continue Reading 0

us corporate news

ParkerVision, Inc. 2025 Annual Report: Patent Enforcement, Licensing, and Cybersecurity Risk Management

Minichart

March 24, 2026

ParkerVision 2025 Annual Report: Key Details for Investors ...

Continue Reading 0

us corporate news

Bionano Genomics 2025 Annual Report Highlights: Optical Genome Mapping, Market Expansion, and Risk Factors 57596054

Minichart

March 24, 2026

Bionano Genomics 2025 Annual Report - Investor Highlights ...

Continue Reading 0

us corporate news

Context Therapeutics 2025 Annual Report: Business Strategy, Risk Factors, Clinical Pipeline, and Regulatory Insights

Minichart

March 24, 2026

Context Therapeutics Inc. 2025 Annual Report Analysis In...

Continue Reading 0